NLRP3 and amyotrophic lateral sclerosis: Although this evidence suggests that the NLRP3 inflammasome is a potential therapeutic target for ALS, whether the microglia similarly sense PR-DPR stimulation and initiate NLRP3 inflammasome activation and the detailed mechanisms in the pathogenesis of C9-ALS remain unclear.